The Impact of Alendronate on Bone Mineral Density of Osteoporotic Patients

The Impact of Alendronate on Bone Mineral Density of Osteoporotic Patients

The present study assessed the real life therapeutic effects of weekly doses of alendronate in treating a group of osteoporotic patients in Iran. The present historical cohort was conducted on patients who had undergone two or more bone mineral densitometry within an interval of 1.5-2 years in Shari...

Full description

Bibliographic Details
Main Authors:	Hamidreza Aghaei-Meybodi, Negin Rashidi, Mahdi Montazeri, Abbasali Keshtkar, Patricia Khashayar
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2013-12-01
Series:	Acta Medica Iranica
Subjects:	Alendronate Bone density Osteoporosis
Online Access:	https://acta.tums.ac.ir/index.php/acta/article/view/4334

Similar Items

Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
by: Fatemeh Khanizadeh, et al.

Evaluation of Alendronate Efficacy on Bone Mineral Density in Thalassemic Patients
by: Fatemeh Shirani, et al.
Published: (2012-10-01)

Evaluation of Alendronate Efficacy on Bone Mineral Density in Thalassemic Patients
by: Fatemeh Shirani, et al.
Published: (2015-10-01)

The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
by: S. Akı, et al.
Published: (2002-03-01)

Short term sodium alendronate administration improves the peri-implant bone quality in osteoporotic animals
by: Danila de OLIVEIRA, et al.

Association Between CTSK Gene Polymorphisms and Response to Alendronate Treatment in Postmenopausal Chinese Women with Low Bone Mineral Density
by: Yuan H, et al.
Published: (2023-10-01)

Efficacy and safety of alendronic acid in the treatment of osteoporosis in children
by: Alberto Martín Siguero, et al.
Published: (2015-11-01)

Comparison of the effect of alendronate and pamidronate on bone density of patients with osteoporosis
by: Zohre Nobakht, et al.
Published: (2018-12-01)

Bone-targeted polymeric nanoparticles as alendronate carriers for potential osteoporosis treatment
by: Chunlan Jing, et al.
Published: (2022-06-01)

The Effect of Alendronate and Intranasal Calcitonin Treatments on Bone Mineral Density in Men with Idiopathic Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2003-03-01)

Evaluation of bone remodelling parameters after one year treatment with alendronate in postmenopausal women with osteoporosis
by: Elma Kučukalić-Selimović, et al.
Published: (2011-02-01)

Effects of Alendronate and Raloxifene on Bone Density and Bone Turnover Markers in Postmenopausal Women
by: Ebru Zülfikaroğlu, et al.
Published: (2011-04-01)

In vivo study of bovine hydroxyapatite-gelatin-hydroxypropyl methylcellulose with alendronate as injectable bone substitute composite in osteoporotic animal model
by: Aniek Setiya Budiatin, et al.
Published: (2022-01-01)

Efficacy and Safety of Generic Alendronate for Osteoporosis Treatment
by: Jarusriwanna A, et al.
Published: (2024-02-01)

The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus: A Danish Retrospective Cohort Study
by: Rikke Viggers, et al.
Published: (2022-01-01)

Effects of Teriparatide and Alendronate on Functional Recovery from Spinal Cord Injury and Postinjury Bone Loss
by: Shuai Wang, et al.
Published: (2025-02-01)

The Effect of Alendronate in Male Osteoporosis
by: Özlem El, et al.
Published: (2004-12-01)

Alendronate loaded graphene oxide functionalized collagen sponge for the dual effects of osteogenesis and anti-osteoclastogenesis in osteoporotic rats
by: Yuyang Zeng, et al.
Published: (2020-12-01)

REVIEW OF BASIC CLINICAL TRIALS OF ALENDRONATE
by: E G Zotkin, et al.
Published: (2010-03-01)

Ångstrom-scale gold particles loaded with alendronate via alpha-lipoic acid alleviate bone loss in osteoporotic mice
by: Weihang Gao, et al.
Published: (2024-04-01)

Bone mineral density status and the need for anti-osteoporotic therapy in postmenopausal women with systemic scleroderma
by: O. V. Dobrovolskaya, et al.
Published: (2019-06-01)

The Findings of Bone Mineral Densitometry Following Preventive Treatment with Alendronate in Menopausal Women with Osteopenia; What is the Best Dose?
by: Mansour Karimifar, et al.
Published: (2020-12-01)

The Gradual Release of Alendronate for the Treatment of Critical Bone Defects in Osteoporotic and Control Rats
by: Hedvičáková V, et al.
Published: (2023-02-01)

The Effect of Alendronate and Calcitonin Treatments on Bone Mineral Density and Quality of Life in Women With Postmenopausal Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2002-06-01)

Comparison of the Efficacy of Daily and Weekly Oral Alendronate Treatment in Patients with Secondary Osteoporosis
by: Sezer Acar, et al.
Published: (2019-12-01)

Use of alendronate in the therapy of osteoporosis
by: O. B. Ershova
Published: (2020-01-01)

Irrational use of alendronate sodium by the elderly
by: Camila Pereira Alvim, et al.
Published: (2020-11-01)

Two Years of Alendronate and Calcitonin Treatments for Osteoporosis in Postmenopausal Women - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

The comparison of effects of alendronate and raloxifene treatment in postmenauposal women with osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2005-12-01)

Site-activatable targeting of macromolecular alendronate for accelerated fracture healing
by: Makoto Matsui, et al.
Published: (2023-12-01)

Alendronate-Induced Osteonecrosis of the Jaw in an Elderly Female
by: Bi-Wei Jan, et al.
Published: (2012-06-01)

The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial
by: Pokpong Piriyakhuntorn, et al.
Published: (2023-05-01)

Experience with Alendronate Treatment for Four Years among Japanese Men with Osteoporosis or Osteopenia and Clinical Risk Factors for Fractures [Retraction]
by: Iwamoto J, et al.
Published: (2022-08-01)

Alendronate Functionalized Bone-Targeting Pomolic Acid Liposomes Restore Bone Homeostasis for Osteoporosis Treatment
by: Xia D, et al.
Published: (2024-08-01)

Alendronate-associated Polyarticular Synovitis: A Case Report
by: Büşra Şirin, et al.
Published: (2024-04-01)

The Comparison of Effects of Alendronate and Calcitonin Treatment in Men With Osteoporosis
by: Gülcan Gürer, et al.
Published: (2004-09-01)

The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
by: İlker Çorapçı, et al.
Published: (2004-03-01)

Facile fabrication of phosphazene-quercetin-alendronate composites as pH-responsive bone-targeted nanomedicine for osteoporosis treatment
by: Xiaowei Yang, et al.
Published: (2024-05-01)

Circular RNA atlas in osteoclast differentiation with and without alendronate treatment
by: Jianbiao Lin, et al.
Published: (2020-07-01)

Cost‐Effectiveness of Sequential Teriparatide/Alendronate Versus Alendronate‐Alone Strategies in High‐Risk Osteoporotic Women in the US: Analyzing the Impact of Generic/Biosimilar Teriparatide
by: Takahiro Mori, et al.
Published: (2019-11-01)